BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Albert CM, Cook NR, Pester J, Moorthy MV, Ridge C, Danik JS, Gencer B, Siddiqi HK, Ng C, Gibson H, Mora S, Buring JE, Manson JE. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. JAMA 2021;325:1061-73. [PMID: 33724323 DOI: 10.1001/jama.2021.1489] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Neumann FA, Jagemann B, Makarova N, Börschel CS, Aarabi G, Gutmann F, Schnabel RB, Zyriax B. Mediterranean Diet and Atrial Fibrillation: Lessons Learned from the AFHRI Case–Control Study. Nutrients 2022;14:3615. [DOI: 10.3390/nu14173615] [Reference Citation Analysis]
2 Siddiqi HK, Vinayagamoorthy M, Gencer B, Ng C, Pester J, Cook NR, Lee IM, Buring J, Manson JE, Albert CM. Sex Differences in Atrial Fibrillation Risk: The VITAL Rhythm Study. JAMA Cardiol 2022. [PMID: 36044209 DOI: 10.1001/jamacardio.2022.2825] [Reference Citation Analysis]
3 Quispe R, Sweeney T, Varma B, Agarwala A, Michos ED. Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention. Curr Atheroscler Rep 2022. [PMID: 35895246 DOI: 10.1007/s11883-022-01052-4] [Reference Citation Analysis]
4 Teramoto T, Ogawa H, Ueshima H, Okada Y, Haze K, Matsui S, Fujikawa K, Hashimoto T, Sakui S, Nishimura K, Kajita M, Horimoto A, Fernandez J. Effect of omega-3 fatty acids on cardiovascular events in high-risk patients with hypertriglyceridemia in Japan: a 3-year post-marketing surveillance study (OCEAN3 survey). Expert Opin Drug Saf 2022. [PMID: 35772177 DOI: 10.1080/14740338.2022.2094914] [Reference Citation Analysis]
5 Zhang N, Wang Y, Chen Z, Liu D, Tse G, Korantzopoulos P, Letsas KP, Goudis CA, Lip GYH, Li G, Zhang Z, Liu T. Circulating Vitamin D Concentrations and Risk of Atrial Fibrillation: A Mendelian Randomization Study Using Non-deficient Range Summary Statistics. Front Nutr 2022;9:842392. [DOI: 10.3389/fnut.2022.842392] [Reference Citation Analysis]
6 Acharya P, Safarova MS, Dalia T, Bharati R, Ranka S, Vindhyal M, Jiwani S, Barua RS. Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Atrial Fibrillation. Am J Cardiol 2022;173:56-63. [PMID: 35369930 DOI: 10.1016/j.amjcard.2022.02.040] [Reference Citation Analysis]
7 Ohlrogge AH, Brederecke J, Ojeda FM, Pecha S, Börschel CS, Conradi L, Rimkus V, Blankenberg S, Zeller T, Schnabel RB. The Relationship Between Vitamin D and Postoperative Atrial Fibrillation: A Prospective Cohort Study. Front Nutr 2022;9:851005. [PMID: 35619954 DOI: 10.3389/fnut.2022.851005] [Reference Citation Analysis]
8 Barsan M, Brata AM, Ismaiel A, Dumitrascu DI, Badulescu A, Duse TA, Dascalescu S, Popa SL, Grad S, Muresan L, Maerescu CM, Cismaru G, Brata VD. The Pathogenesis of Cardiac Arrhythmias in Vitamin D Deficiency. Biomedicines 2022;10:1239. [DOI: 10.3390/biomedicines10061239] [Reference Citation Analysis]
9 Martin A, Lang S, Goeser T, Demir M, Steffen HM, Kasper P. Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease. Curr Atheroscler Rep 2022. [PMID: 35507279 DOI: 10.1007/s11883-022-01028-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gaba P, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Tardif JC, Giugliano RP, Martens FMAC, Gibson CM, Ballantyne CM; REDUCE-IT Investigators. Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction. J Am Coll Cardiol 2022;79:1660-71. [PMID: 35483753 DOI: 10.1016/j.jacc.2022.02.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
11 Quispe R, Al Faddagh A, Kazzi B, Zghyer F, Marvel FA, Blumenthal RS, Sharma G, Martin SS. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis. Curr Atheroscler Rep 2022. [PMID: 35499805 DOI: 10.1007/s11883-022-01031-9] [Reference Citation Analysis]
12 Andelova K, Bacova BS, Sykora M, Hlivak P, Barancik M, Tribulova N. Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress. Int J Mol Sci 2022;23:1416. [PMID: 35163340 DOI: 10.3390/ijms23031416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 Myhre PL, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Solheim S, Arnesen H, Seljeflot I. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial. J Intern Med 2022. [PMID: 34982486 DOI: 10.1111/joim.13442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Egan Benova T, Viczenczova C, Szeiffova Bacova B, Zurmanova J, Knezl V, Andelova K, Tribulova N. Omacor Protects Normotensive and Hypertensive Rats Exposed to Continuous Light from Increased Risk to Malignant Cardiac Arrhythmias. Mar Drugs 2021;19:659. [PMID: 34940658 DOI: 10.3390/md19120659] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Lin Z, Ni L, Teng C, Zhang Z, Wu L, Jin Y, Lu X, Lin Z. Eicosapentaenoic Acid-Induced Autophagy Attenuates Intervertebral Disc Degeneration by Suppressing Endoplasmic Reticulum Stress, Extracellular Matrix Degradation, and Apoptosis. Front Cell Dev Biol 2021;9:745621. [PMID: 34805156 DOI: 10.3389/fcell.2021.745621] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Doshi R, Majmundar M, Kumar A, Patel K, Vallabhajosyula S, Kalra A. Association of new-onset atrial fibrillation in patients taking high-dose fish oil. Eur J Intern Med 2021;94:110-1. [PMID: 34593295 DOI: 10.1016/j.ejim.2021.09.010] [Reference Citation Analysis]
17 Barry AR, Dixon DL. Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular disease. Pharmacotherapy 2021;41:1056-65. [PMID: 34431129 DOI: 10.1002/phar.2615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Benjamin EJ, Al-Khatib SM, Desvigne-Nickens P, Alonso A, Djoussé L, Forman DE, Gillis AM, Hendriks JML, Hills MT, Kirchhof P, Link MS, Marcus GM, Mehra R, Murray KT, Parkash R, Piña IL, Redline S, Rienstra M, Sanders P, Somers VK, Van Wagoner DR, Wang PJ, Cooper LS, Go AS. Research Priorities in the Secondary Prevention of Atrial Fibrillation: A National Heart, Lung, and Blood Institute Virtual Workshop Report. J Am Heart Assoc 2021;:e021566. [PMID: 34351783 DOI: 10.1161/JAHA.121.021566] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
19 Jia X, Gao F, Pickett JK, Al Rifai M, Birnbaum Y, Nambi V, Virani SS, Ballantyne CM. Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther 2021;35:793-800. [PMID: 34057665 DOI: 10.1007/s10557-021-07204-z] [Reference Citation Analysis]
20 Kow CS, Doi SAR, Hasan SS. The coincidence of increased risk of atrial fibrillation in randomized control trials of omega-3 fatty acids: a meta-analysis. Expert Rev Clin Pharmacol 2021;14:773-5. [PMID: 33798016 DOI: 10.1080/17512433.2021.1913051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]